Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Shanghai Pharmaceuticals Holding Co., Ltd. has announced its unaudited interim financial results for the first half of 2024, revealing a consolidated net profit of RMB 2.94 billion. The company plans to reward shareholders with a cash dividend of RMB 0.80 per ten shares, which amounts to 10.07% of its net profit. The interim report, yet to be audited, confirms that there are no significant risks affecting the company’s operations during the reporting period.
For further insights into HK:2607 stock, check out TipRanks’ Stock Analysis page.
